Stance Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.92M Buy
+37,323
New +$3.01M 0.89% 24
2026
Q1
Sell
-14,011
Closed -$1.35M 305
2025
Q4
$1.35M Sell
14,011
-279
-2% -$27.1K 0.49% 106
2025
Q3
$1.36M Buy
+14,290
New +$1.31M 0.5% 83
2025
Q1
Sell
-160
Closed -$12.8K 177
2024
Q4
$12.8K Buy
+160
New +$13.9K 0.01% 169

Other funds holding MDT

Stance Capital's MDT Position: Q2 2026 in Review

Stance Capital opened a new position in Medtronic (MDT) in Q2 2026: 37,323 shares worth $2.92M. The stake represents 0.89% of the portfolio and ranks #24 among its holdings. This is a return to the name: Stance Capital previously reported a position in MDT as recently as Q4 2025.

Stance Capital first reported a position in MDT in Q4 2024 and has held it in 4 quarters since. 2,137 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Stance Capital held 37,323 shares of Medtronic worth $2.92M as of Q2 2026.
  • Medtronic was a new Stance Capital position in Q2 2026.
  • Medtronic made up 0.89% of Stance Capital's portfolio in Q2 2026, its #24 holding.
  • Stance Capital first reported a position in Medtronic in Q4 2024 and has held it in 4 quarters since.
  • 2,137 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.